Biological Sciences Division
Published May 16, 2019 | Version v1
Patent Open

METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES

Creators

  • 1. University of Chicago
  • 2. Max Planck Institute of Biochemistry
  • 3. Max Delbrück Center for Molecular Medicine

Contributors

Description

The current disclosure relates to methods for treating ovarian cancer based on specific antigen expression of the cancer. Furthermore, the expressed antigen may be used in immunotherapeutic methods for treatment of the ovarian cancer. Aspects of the disclosure relate to immunotherapies targeting CT45 polypeptides, methods for treating ovarian cancer based on CT45 expression, and kits for detecting CT45 polypeptides and nucleotides.

Files

US20190144516.pdf

Files (4.8 MB)

Name Size Download all
md5:3b0c62668fe8fed05c614a8c6b1de417
4.8 MB Preview Download

Additional details

Identifiers

Patent application number
US 201716300267 A
Patent number
US 2019/0144516 A1
Other
oai:uchicago.tind.io:8317

Dates

Patent filed
2017-05-11

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine, Cancer Biology